1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine

Detalles Bibliográficos
Autores principales: Felip, E., Hernandez, A., Notario, L., Cucurull, M., Quirant, B., Saigí, M., Gómez-Castellà, R., Estevez-Macas, E., Fonollosa, S. Coll, Bertral, P. Torres, Costa, E. Carcereny, Domenech, M., Estival, A., Paradís, A. López, Badía, A. Pous, Marín, M. Romeo, Bueno, M.T. Moran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454346/
http://dx.doi.org/10.1016/j.annonc.2021.08.1584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454346/
http://dx.doi.org/10.1016/j.annonc.2021.08.1584

Ejemplares similares